# A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI

> **NCT02989558** · PHASE3 · COMPLETED · sponsor: **University of Athens** · enrollment: 90 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DRUG:** Ticagrelor plus ASA
- **DRUG:** Clopidogrel plus ASA

## Key facts

- **NCT ID:** NCT02989558
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2020-02-01
- **Final completion:** 2021-02-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02989558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02989558, "A Trial to Assess the Safety and Efficacy of Prophylactic TicagrelOr With Acetylsalicylic Acid Versus CLopidogrel With Acetylsalicylic Acid in the Development of Cerebrovascular EMbolic Events During TAVI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02989558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*